脉络宁注射液辅助治疗急性脑梗死的临床观察

摘要

OBJECTIVE:To observe clinical efficacy and safety of Mailuoning injection in adjunctive treatment of acute cere-bral infarction. METHODS:A total of 65 patients with acute cerebral infarction selected from neurology department of our hospital were divided into control group(32 cases)and observation group(33 cases)according to random number table. Control group was given conventional treatment. Observation group was additionally given Mailuoning injection 10 mL added into 0.9% sodium chlo-ride injection 250 mL intrnrenously,ivgtt,qd,on the basis of control group. Both group were treated for 15 d. Clinical efficacy as well as serum levels of ox-LDL,BNP and MMP-9,NIHSS score before and after treatment,the occurrence of ADR were com-pared between 2 groups. RESULTS:The response rate of observation group was 90.91%,which was significantly higher than 65.63%,with statistical significance(P0.05). After treatment,serum levels of ox-LDL,BNP and MMP-9,NIHSS score in 2 groups were all decreased significantly,and the observation group was significantly lower than the control group,with statis-tical significance (P0.05). CONCLU-SIONS:Mailuoning injection has significant therapeutic efficacy for acute cerebral infarction,can significantly reduce serum levels of ox-LDL,BNP and MMP-9,promotes neurological function and the recovery of patients with cerebral infarction with good safety.%目的:观察脉络宁注射液辅助治疗急性脑梗死的临床疗效及安全性.方法:选择在我院神经内科确诊的65例急性脑梗死患者作为研究对象,按随机数字表法分为对照组(32例)和观察组(33例).对照组患者给予常规基础治疗,观察组患者在对照组基础上加用脉络宁注射液10 mL加入0.9%氯化钠注射液250 mL中,ivgtt,qd.两组患者疗程均为15 d.比较两组患者临床疗效及治疗前后血清氧化低密度脂蛋白(ox-LDL)、脑钠肽(BNP)、基质金属蛋白酶9(MMP-9)水平和美国国立卫生研究院卒中量表(NIHSS)评分以及治疗过程中不良反应发生情况.结果:观察组的有效率为90.91%,显著高于对照组的65.63%,差异有统计学意义(P0.05);治疗后,两组患者血清ox-LDL、BNP及MMP-9水平和NIHSS评分均显著降低,且观察组显著低于对照组,差异均有统计学意义(P0.05).结论:脉络宁注射液辅助治疗急性脑梗死疗效显著,能明显降低患者血清ox-LDL、BNP及MMP-9水平,改善神经功能促进脑梗死患者的恢复,且安全性较好.